Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes
OPEN Diabetes therapy : research, treatment and education of diabetes and related disorders | 13 Apr 2017
T Haak, H Hanaire, R Ajjan, N Hermanns, JP Riveline and G Rayman
Published evaluations of sensor glucose monitoring use in insulin treated type 2 diabetes are limited. The aim of this study was to assess the impact of flash glucose-sensing technology as a replacement for self-monitoring of blood glucose (SMBG) over a 12-month period in participants with type 2 diabetes who were on intensive insulin therapy.
* Data courtesy of Altmetric.com